Dermatology Doctors in Goodyear, AZ Accepting Medicare

5 Dermatology doctors found. Showing 1 - 5

Walter J Lewis, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 14537 W Indian School Rd, #700, Goodyear, AZ 85395 Phone: 623-935-0247    Fax: 623-974-9351

Mr. Kevin Lee Svancara, D.O. Dermatology - Clinical & Laboratory Dermatological Immunology Medicare: Accepting Medicare Assignments Practice Location: 2620 N 140th Ave # 103, Goodyear, AZ 85395 Phone: 623-219-4777    Fax: 623-219-4778

Rita M George, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14537 W Indian School Rd, 700, Goodyear, AZ 85395 Phone: 623-935-0247    Fax: 623-935-2209

John R Haydon Jr., MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 14537 W Indian School Rd, 700, Goodyear, AZ 85395 Phone: 623-935-0247    Fax: 623-935-2209

Valerie L Huls, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14537 W Indian School Rd, #700, Goodyear, AZ 85395 Phone: 623-935-0247    Fax: 623-935-2209

News Archive

Scientists discover new serine protease: NSP4

Neutrophil granulocytes comprise important defences for the immune system. When pathogenic bacteria penetrate the body, they are the first on the scene to mobilise other immune cells via signal molecules, thereby containing the risk. To this end, they release serine proteases - enzymes that cut up other proteins to activate signal molecules. Scientists at the Max Planck Institute of Neurobiology in Martinsried have now discovered a new serine protease: neutrophil serine protease 4, or NSP4.

Research: Getting reminder texts helps patients take heart medicines more regularly

Getting reminder texts helped patients take their heart medicines (anti-platelet and cholesterol-lowering drugs) more regularly, according to research presented at the American Heart Association's Scientific Sessions 2013.

Child Survival Call to Action sign that U.S. government looking to collaborate on foreign aid

"The Child Survival Call to Action shows the U.S. government navigating a new approach to global health and development," Nellie Bristol, global health research fellow at the Center for Strategic & International Studies (CSIS), and Janet Fleischman, senior associate at the CSIS Global Health Policy Center, write in a post on the center's "Smart Global Health" blog.

Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate

Amira Pharmaceuticals, Inc. announced today the submission of an Investigational New Drug application (IND) of AM461, its internally-discovered, oral drug candidate for the treatment and control of inflammatory and allergic disease linked to the arachidonic acid pathway, to the U.S. Food and Drug Administration.

Read more Medical News

› Verified 1 days ago